FDA Inspection
Pacific BioLabs, Inc.Pacific BioLabs, Inc. – FDA Inspection, Sep 25, 2026
Record Details
This FDA Inspection record concerns Pacific BioLabs, Inc., with an inspection on September 25, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · f8e5e071-b870-43b6-987a-35acbd863beb
Inspection Facts
- Inspection number
- 1337886
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pacific BioLabs, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2025 | Not classified | San Francisco District Office | |
| June 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2018 | Not classified | San Francisco District Office | |
| October 27, 2017 | Not classified | San Francisco District Office |
Other documents for Pacific BioLabs, Inc.
- FDA Inspection 1277213 - 2025-07-18
- FDA Inspection 1206864 - 2023-06-01
- FDA Inspection 1046565 - 2018-03-19
- FDA Inspection 1046401 - 2018-02-22
- FDA Inspection 1040908 - 2017-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.